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Abstract
Increased levels of glutamate causing excitotoxic damage accompany neurological disorders such as ischemia ⁄ stroke, epilepsy and
some neurodegenerative diseases. Cyclin-dependent kinase-5 (Cdk5) is important for synaptic plasticity and is deregulated in
neurodegenerative diseases. However, the mechanisms by which kainic acid (KA)-induced excitotoxic damage involves Cdk5 in
neuronal injury are not fully understood. In this work, we have thus studied involvement of Cdk5 in the KA-mediated degeneration of
glutamatergic synapses in the rat hippocampus. KA induced degeneration of mossy fiber synapses and decreased glutamate
receptor (GluR)6 ⁄ 7 and post-synaptic density protein 95 (PSD95) levels in rat hippocampus in vivo after intraventricular injection of
KA. KA also increased the cleavage of Cdk5 regulatory protein p35, and Cdk5 phosphorylation in the hippocampus at 12 h after
treatment. Studies with hippocampal neurons in vitro showed a rapid decline in GluR6 ⁄ 7 and PSD95 levels after KA treatment with
the breakdown of p35 protein and phosphorylation of Cdk5. These changes depended on an increase in calcium as shown by the
chelators 1,2-bis(o-aminophenoxy)ethane-N,N,N ¢,N¢-tetraacetic acid acetoxymethyl ester (BAPTA-AM) and glycol-bis (2-aminoeth-
ylether)-N,N,N ¢,N ¢-tetra-acetic acid. Inhibition of Cdk5 using roscovitine or employing dominant-negative Cdk5 and Cdk5 silencing
RNA constructs counteracted the decreases in GluR6 ⁄ 7 and PSD95 levels induced by KA in hippocampal neurons. The dominant-
negative Cdk5 was also able to decrease neuronal degeneration induced by KA in cultured neurons. The results show that Cdk5 is
essentially involved in the KA-mediated alterations in synaptic proteins and in cell degeneration in hippocampal neurons after an
excitotoxic injury. Inhibition of pathways activated by Cdk5 may be beneficial for treatment of synaptic degeneration and excitotoxicity
observed in various brain diseases.
Introduction
Excitotoxicity with overactivation of ionotropic glutamate receptors
(GluRs) is a major cause of cell death in several neurological diseases.
Excitotoxicity is accompanied by an increase in calcium levels in
neurons with activation of various proteases, such as calpains
(Vanderklish & Bahr, 2000) and caspases (Mattson, 2003). However,
the precise signaling pathways for cell demise in excitotoxicity are not
fully understood. We have previously shown that excitotoxicity
induced by the GluR agonist kainic acid (KA) leads to endoplasmic
reticulum stress in hippocampal neurons with subsequent cell
degeneration (Sokka et al., 2007). Concomitant with changes in
signaling pathways, synaptic proteins are affected in many neurolog-
ical disorders (Korhonen & Lindholm, 2004; Korhonen et al., 2005).
In this work, we have studied the role of cyclin-dependent kinase-5
(Cdk5) in the alterations of synaptic proteins by KA as a means of
understanding early signals mediating excitotoxicity in hippocampal
neurons.
The proline-directed serine ⁄ threonine protein kinase Cdk5 is an
atypical cyclin-dependent kinase expressed primarily in post-mitotic
neurons and activated by binding to the p35 and p39 activator proteins
(Tsai et al., 1994; Cai et al., 1997). Deregulation of Cdk5 secondary
to cleavage of p35 and p39 proteins occurs in some neurodegenerative
diseases (Weishaupt et al., 2003), such as Alzheimer’s disease
(Kobayashi et al., 1993; Noble et al., 2003) and Huntington’s disease
(Paoletti et al., 2008). Lewy bodies, accumulating in Parkinson’s
disease, are also immunoreactive for Cdk5 and p35 proteins (Nakam-
ura et al., 1997).
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It has been shown that Cdk5 is important for synaptic plasticity
and learning, and for normal development of the brain (Ohshima
et al., 1996; Chae et al., 1997; Zhang et al., 1997; Hawasli & Bibb,
2007; Lai & Ip, 2009). Cdk5 influences the clustering of the post-
synaptic density protein 95 (PSD95) complex (Morabito et al.,
2004) and regulates trafficking of metabotropic GluRs (Orlando
et al., 2009) and N-methyl-d-aspartate (NMDA) receptor subunits
(Li et al., 2001). These observations suggest that Cdk5 is important
for the regulation of GluRs and proper synaptic function in the
brain.
Kainate receptors (KARs) are involved in both pre- and post-
synaptic functions in the nervous system, and are important in synaptic
plasticity and learning (Jane et al., 2009; Vincent & Mulle, 2009).
KARs are homo- or heteromeric combinations of five types of subunits,
GluR5 [glutamate receptor ionotropic kainate (GIRK)1] GluR6
(GRIK2), GluR7 (GRIK3), KA1 (GRIK4) and KA2 (GRIK5)
(Jaskolski et al., 2005). As shown using gene-deleted animals, GluR6
is essentially involved in KA-induced epileptic seizures and in
neuronal degeneration in the cornu ammonis (CA)3 region in the
hippocampus (Mulle et al., 1998). In this work, we found that KA
induces an activation of Cdk5 in cultured hippocampal neurons as well
as in the hippocampus in vivo. KA treatment decreased the levels of
GluR6 ⁄ 7 and PSD95 in the hippocampal neurons. Inhibition of Cdk5
using roscovitine, or the use of silencing RNA (siRNA) or dominant-
negative (DN) Cdk5 constructs counteracted the decreases in these
proteins in cultured hippocampal neurons, indicating an important role
of Cdk5 in KA-mediated synaptic degeneration and excitotoxicity.
Materials and methods
Animals
Experiments were approved by the ethical committees at the
University of Helsinki and the University of Palermo, and carried
out in accordance with the European Communities Council Directive
(86 ⁄ 609 ⁄ EEC). Adult male Wistar rats (200–300 g) (B&K, Hull, UK)
were injected with KA (Sigma, Helsinki, Finland) into the lateral
ventricle (0.35 lg ⁄ lL) in a volume of 0.5 lL per side as described
previously (Sokka et al., 2007), and killed at different time-points
from 15 min to 48 h. Controls received an equal volume of saline.
Rats were decapitated under deep anesthesia with chloral hydrate, and
brains were dissected, frozen in isopentane, cooled in liquid nitrogen
and stored at )70 C until analysis. The right side of the brain was
used for histology and the left for western blot analyses.
Neuronal cultures
Hippocampal neurons were prepared from embryonic day 17 Wistar
rats (Harlan, Holland) and plated on poly-ornithine (Sigma)-coated
six-well plates at a density of 2 · 106 cells (2.0 cm2). Cells were
cultured in Neurobasal medium containing 2% B27 as described
previously (Korhonen et al., 2001; Sokka et al., 2007; Kairisalo et al.,
2009). Cell death was induced by treating neurons for different times
with 100 lm KA (Calbiochem, Espoo, Finland), which induces cell
death in approximately 40–50% of the neurons within 24 h as reported
previously (Korhonen et al., 2001; Sokka et al., 2007). In some
experiments, 1–10 lm 1,2-bis(o-aminophenoxy)ethane-N,N,N¢,N¢-
tetra-acetic acid acetoxymethyl ester (BAPTA-AM) (Sigma), 20 lm
roscovitine (Sigma) or 2 mm glycol-bis(2-aminoethylether)-
N,N,N¢,N¢-tetra-acetic acid (EGTA) was added 10–60 min before
KA.
Modulation of cyclin-dependent kinase-5 in neurons
To downregulate Cdk5, 5 · 106 neurons were transfected with 100 nm
siRNA constructs against Cdk5 (On TargetPlus Smartpool, Dharma-
con) using the Rat Neuron Nucleofector system (Amaxa GmbH,
Germany) essentially as described previously (Kairisalo et al., 2009).
A scrambled siRNA construct was used as control. Cdk5 activity was
also inhibited using the DN-Cdk5 expression plasmid with mutation in
the active site (D144N) linked to the hemagglutinin epitope (van den
Heuvel & Harlow, 1993) or to enhanced green fluorescent protein
(EGFP) (courtesy of Dr Tsai, Massachusetts Institute of Technology,
USA). The DN-Cdk5-EGFP was transfected into hippocampal neurons
as above, and the vector containing EGFP was used as control. After
5 days in culture, neurons were treated with 100 lm KA for 1–24 h
and immunoblots were made as described below.
Calcium imaging
Hippocampal neurons plated on polyornithine-coated glass coverslips
were loaded with 4 lm fura-2 acetoxymethyl ester (Invitrogen,
Carlsbad, CA, USA) for 20 min at 37 C in Hepes-buffered medium
(137 mm NaCl, 5 mm KCl, 1 mm CaCl2, 1.2 mm MgCl2, 0.44 mm
KH2PO4, 4.2 mm NaHCO3, 10 mm glucose, 20 mm Hepes, pH 7.4),
rinsed once and used immediately. Ca2+ measurements were per-
formed at 35 C using a Nikon TE2000 fluorescence microscope
[magnification 20· and numerical aperture 0.75 (20· ⁄ 0.75) air
objective] and Andor iXon 885 EM-CCD camera under the control of
Nikon nis elements ar software with 6D extension essentially as
described previously (Korhonen et al., 2005; Reijonen et al., 2010).
For Ca2+ imaging, the cells were excited with alternating 340 and
380 nm light (Sutter DG4 Plus) and the emitted light collected through
a 400 nm dichroic mirror and a 450 nm long-pass filter. Transfected
cells were selected based upon EGFP fluorescence. Additions were
made by constant perfusion (Hepes-buffered medium). Regions of
interest (cell bodies) were defined in nis software and the data
extracted to Microsoft Excel for visualization and quantification. A
total of 19–70 cells were measured in each experiment, and each
experiment was repeated four times or more.
Western blotting
Immunoblotting was performed essentially as described previously
(Korhonen et al., 2001; Sokka et al., 2007; Reijonen et al., 2008;
Kairisalo et al., 2009). In brief, hippocampal tissue and neurons were
lysed using ice-cold radioimmunoprecipitation assay buffer (150 mm
NaCl, 1% Triton-X-100, 0.5% sodium deoxycholate, 1% sodium
dodecyl sulfate, 50 mm Tris–HCl, pH 7.4) supplemented with protease
inhibitor cocktail (Roche, Espoo, Finland) and phosphatase inhibitors
(PhoStop; Roche). Equal amounts of protein were subjected to sodium
dodecyl sulfate–polyacrylamide gel electrophoresis and blotted onto
nitrocellulose filters (Amersham, Helsinki, Finland), which were
incubated for 1 h in 5% skimmed milk or bovine serum albumin, in
50 mm Tris–HCl, pH 7.5, 150 mm NaCl, 0.1% Tween-20 and then
with primary antibodies overnight at 4 C. These included antibodies
against GluR6 ⁄ 7 (diluted 1 : 1000, no. 04-921; Millipore ⁄Upstate),
PSD95 (1 : 2000, no. 610496; BDBiosciences, VWR International Oy,
Espoo, Finland), Cdk5 (1:2000, no. 05-364; Millipore ⁄Upstate),
[phospho-cyclin-dependent-kinase-5 (p-Cdk5)(tyrosine 15)](Y15)
(1:1000, no. sc-12918; Santa Cruz Biotechnologies, AH Diagnostics,
Helsinki, Finland), p35 ⁄ 25 (1 : 1000, no. C64B10, Cell Signaling
Technologies, Finnzymes, Helsinki, Finland) and b-actin (1 : 1000, no.
2066; Sigma). After washing, the filter was incubated with horseradish
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peroxidase-conjugated secondary antibodies (1 : 2500; Jackson
ImmunoResearch Laboratories, Espoo, Finland), followed by detection
using enhanced chemiluminescence (Pierce, Helsinki, Finland). Quan-
tifications were performed using the imagej software (version 1.41o).
Immunochemistry
In vivo
Rat brain sections (10 lm) were fixed for 10 min at )20 C using
acetone:methanol (1 : 1). Slides were incubated for 1 h with
phosphate-buffered saline ⁄ 5% bovine serum albumin (Sig-
ma) ⁄ 0.1% Triton-X-100 at room temperature (20 C), and then
overnight at 4 C with primary antibodies [PSD95 (1 : 500; no.
12093; Abcam), GluR6 ⁄ 7 (1 : 100), neuronal nuclei (1 : 100;
MAB377, Millipore ⁄ Chemicon) or b-tubulin (1 : 500; MMS-
4351, Nordic Biosite ⁄ Covance)] followed by secondary Alexa
488- or 594-conjugated antibodies (1 : 500; Jackson ImmunoRe-
search Laboratories). The nuclei were counterstained with bisbenzi-
mide ⁄Hoechst 33258 (Sigma).
In vitro
Neurons were fixed for 20 min using 4% paraformaldehyde, incubated
for 1 h using phosphate-buffered saline ⁄ 5% bovine serum albu-
min ⁄ 0.1% Triton-X and stained as above with antibodies for
GluR6 ⁄ 7, PSD95, p-Cdk5 and synapsin I (1 : 500, no. 61392; Nordic
Biosite ⁄Covance). Stainings were visualized by fluorescent micro-
scope (Leica DM4500B, Espoo, Finland).
Cell degeneration assay
In vivo
Fluoro-Jade staining for degenerating nerve cells was performed
essentially as described previously (Korhonen et al., 2001, 2005;
Sokka et al., 2007).
In vitro
Hippocampal neurons were transfected with DN-Cdk5-EGFP or with
EGFP expression vector as above. KA (100 lm) was added for 24 h
and the nuclei were labeled with Hoechst 33258 blue (Sigma). The
number of cells with condensed or fragmented chromatin was counted
as an index of degenerating neurons.
Confocal imaging
Neurons were analyzed at room temperature with a confocal
microscope (LSM 510 Meta; Carl Zeiss, Inc.) using lsm aim
software and a magnification 63· and numerical aperture 1.4
(63· ⁄ 1.4) Plan-Apochromat oil objective. Images were
processed using imagej and adobe photoshop CS software.
Quantification and statistics
Statistical comparisons were performed using one-way anova
followed by a Bonferroni or Tukey’s (if more than five groups)
post-hoc test. The Student’s unpaired t-test was used in experiments
with two groups. P £ 0.05 was considered significant. Four to eight
rats were used for each time point in vivo, and the in vitro assays
were repeated more than three times. Values are expressed as
mean ± SEM.
Results
Kainic acid induces synaptic degeneration and decreases
post-synaptic density protein 95 and glutamate receptor 6 ⁄ 7
levels in rat hippocampal neurons in vivo
To study the hippocampal pathways altered in excitotoxicity, we
treated rats with KA in vivo as described in Materials and methods.
Intraventricular injections of KA have been shown to mainly cause
cell degeneration of neurons in the CA3 region of the hippocampus as
well as in the amygdala and less cell degeneration of CA1 neurons,
which is observed more with intraperitoneal injections. To study
neuronal degeneration, we used Fluoro-Jade, which has been shown to
detect both degenerating cell bodies and dendrites after excitotoxicity-
induced injuries in rat retina (Chidlow et al., 2009) and dopaminergic
neurons (El-Khodor & Burke, 2002). Fluoro-Jade D staining revealed
a degeneration of neurites in the hippocampal CA3 area in the KA-
treated rats (Fig. 1A) and a reduction in PSD95-positive synaptic
terminals in the CA3 area in the hippocampus (Fig. 1B). Immuno-
blotting of tissue lysates showed a reduction in PSD95 levels in the
hippocampus at 12–48 h after KA administration (Fig. 1C; one-way
anova with Bonferroni post-hoc test and Student’s unpaired t-test,
P < 0.01 for control vs. 12 h KA and P < 0.05 for control vs. 48 h
and 72 h KA).
We then studied the effect of KA on GluR6, which is a subtype of
GluR in the brain that is important for KA-mediated effects (Mulle
et al., 1998). For this we used an antibody that recognizes both GluR6
and GluR7 receptor subtypes, and therefore we here use the term
GluR6 ⁄ 7. It is of note that the expression of GluR7 is very low in the
hippocampus particularly in the CA3 area (Bureau et al., 1999), and
thus our data may primarily reflect changes in GluR6. Immunostaining
data showed that GluR6 ⁄ 7 decreased in the CA3 area of the
hippocampus at 12–24 h after KA administration (Fig. 1D). Double
staining using antibodies against neuronal nuclei, microtubuli
(b-tubulin) and GluR6 ⁄ 7 indicated that the decrease in GluR6 ⁄ 7 in
the mossy fiber area after KA occurred with the preservation of the cell
soma of many CA3 neurons (Fig. 1E). Immunoblotting of tissue
lysates also showed a downregulation of GluR6 ⁄ 7 in the hippocampus
at 3 h after KA administration with a rebound at longer times that may
reflect new synthesis of the receptor during the recovery phase
(Fig. 1F; one-way anova with Bonferroni post-hoc test, P < 0.01 for
control vs. 6 h KA and P < 0.05 for control vs. 3, 12, 24 and 72 h
KA).
Kainic acid also decreases post-synaptic density protein 95 and
glutamate receptor 6 ⁄ 7 levels in hippocampal neurons in vivo
The effects of KA in vivo are rather complex and reflect changes in
individual neurons, as well as alterations in neuronal circuits and in
activation of glial cells that occur with time. To obtain a more detailed
and mechanistic insight into the KA-mediated effects, we studied
cultured hippocampal neurons prepared from rat hippocampus. Data
showed that KA also induced a decrease in PSD95 levels in cultured
hippocampal neurons that occurred within the first hours of incuba-
tion, as shown by immunostaining and immunoblots (Fig. 2A and B;
one-way anova with Bonferroni post-hoc test, P < 0.01 control vs. 1
and 3 h KA).
Immunostaining of GluR6 ⁄ 7 in the hippocampal neurons showed
that the addition of KA also rapidly reduced GluR6 ⁄ 7, observed
particularly within the dendrites of hippocampal neurons (Fig. 2C).
Immunoblotting confirmed that the levels of GluR6 ⁄ 7 in the
hippocampal neurons decreased markedly within the first 30 min
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after KA addition (Fig. 2D and E; one-way anova with Tukey’s
post-hoc test, P < 0.01 for control vs. 30 min-24 h KA). This decrease
in GluR6 ⁄ 7 by KA in vitro was more robust and long lasting than that
observed in vivo (cf. Fig. 1F), suggesting that there is a more fine-
tuned regulation of GluR6 ⁄ 7 levels in brain compared with the in vitro
situation.
Kainic acid induces a calcium- and calpain-dependent cleavage
of p35 protein in cultured hippocampal neurons
The activation of GluRs is linked to increases in intracellular calcium
that in turn affect various signaling molecules in neurons. We have
previously shown that KA induces endoplasmic reticulum stress and
increases calcium levels in cultured hippocampal neurons (Sokka
et al., 2007). In a search for changes in upstream molecules, we
observed that treatment of cultured hippocampal neurons with 100 lm
KA caused a cleavage of the Cdk5 activator protein p35 into the p25
fragment that started at about 15 min after KA addition (Fig. 3A and
B; one-way anova with Bonferroni post-hoc test, P < 0.01 control vs.
15 min-3 h KA). To study whether the breakdown of p35 by KA was
linked to changes in calcium levels, we analyzed the dose- and time-
dependent calcium movements in KA-treated hippocampal neurons.
Data showed that KA treatment resulted in a dose-dependent increase
in intracellular calcium level (Fig. 3C) with the activation of the
calcium-dependent protease calpain, shown by the accumulation of
calpain-specific 145 kDa cleavage products of a-spectrin (Fig. 3D).
Inhibition of the intracellular calcium increase by the chelation of
intracellular or extracellular calcium using BAPTA-AM (Fig. 3E and
F; one-way anova with Bonferroni post-hoc test, P < 0.01 for control
vs. KA and P < 0.01 for KA vs. KA+BAPTA-AM) or EGTA (Fig. 3G
and H), respectively, attenuated the accumulation of p25 brought about
by KA. In addition, the calpain inhibitor XI prevented the p35
cleavage by KA, indicating that calpain is involved in this process
(Fig. 3G and H; one-way anova with Bonferroni post-hoc test,
P < 0.01 for control vs. KA and P < 0.01 for KA vs. EGTA+KA and
P < 0.01 for KA vs. XI+KA).
Kainic acid induces an increase in cyclin-dependent kinase-5
phosphorylation in hippocampal neurons in culture and in vivo
Previous studies have shown that the cleavage of p35 into p25 results
in the deregulation of Cdk5 with changes in the localization and
stability of Cdk5 (Kusakawa et al., 2000; Lee et al., 2000; Asada
et al., 2008). To study the role of Cdk5 in the excitotoxicity induced
by KA, we analyzed p-Cdk5, as a measure of the increased activation
of this kinase. Data showed that 100 lm KA induced a time-
dependent increase in Cdk5 phosphorylation in the hippocampal
neurons after 30 min of incubation (Fig. 4A and B; one-way anova
with Bonferroni post-hoc test, P < 0.01 for KA vs. 1 h-KA).
Immunostaining further revealed that an accumulation of phosphor-
Fig. 1. KA treatment induces degeneration of hippocampal synapses and reduces levels of PSD95 and GluR6 ⁄ 7 in vivo. (A) Rats were treated with KA for 24 h as
described in Materials and methods. Upper panel: whole hippocampus. Lower panel: higher magnification. Fluoro-Jade staining (green fluorescence) showed cell
degeneration in the rat hippocampal CA3 area by KA. Arrows indicate some of the degenerating neurons. Scale bar: upper panel, 500 lm; lower panel, 100 lm. (B)
Immunostaining was performed as described in Materials and methods. PSD95 immunoreactivity was reduced in the CA3 region. Scale bar, 100 lm. (C)
Immunoblots were made as described in Materials and methods. PSD95 was downregulated after KA and b-actin was used as control (C). Values are means + SEM,
n = 3. **P < 0.01 or *P < 0.05 for KA vs. C. (D) GluR6 ⁄ 7 immunoreactivity (red) in the CA3 area was reduced by KA treatment. Scale bar, 100 lm. (E)
Immunostaining of GluR6 ⁄ 7 (red) in conjunction with the nuclear marker, neuronal nuclei (NeuN), or the microtubule marker, b-tubulin (green), at 12 h of KA
treatment. Note reduction in GluR6 ⁄ 7 with the preservation of neuronal soma. Scale bar, 100 lm. (F) Immunoblot. Note a decrease in GluR6 ⁄ 7 after KA. b-actin
was used as control (C). Values are means + SEM, n = 3. **P < 0.01 or *P < 0.05 for KA vs. C.
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ylated Cdk5 protein occurred within neurites in KA-treated neurons
(Fig. 4C). Pre-treatment of cells with BAPTA-AM or EGTA reduced
the Cdk5 phosphorylation induced by KA (Fig. 4D and E; one-way
anova with Tukey’s post-hoc test, P < 0.01 for control vs. KA,
P < 0.01 for KA vs. EGTA-KA and P < 0.01 for KA vs. BAPTA-
AM+KA), showing an involvement of calcium in the regulation of
Cdk5 by KA. Immunoblots using tissue lysates from KA-treated rats
substantiated the data obtained in vitro, and showed an increase in
p-Cdk5 and in the breakdown of p35 by KA in the hippocampus
occurring mainly at 12 h after KA administration (Fig. 4F and G; one-
way anova with Tukey’s post-hoc test, P < 0.01 for control vs. 12 h
KA vs. control in the case of p-Cdk5 and p25, and P < 0.05 for
control vs. 24–72 h KA in the case of p35).
Inhibition of cyclin-dependent kinase-5 counteracts the effects
of kainic acid in cultured hippocampal neurons
To study the role of Cdk5 in more detail we sought to inhibit its action
in the hippocampal neurons. Pre-treatment of the neurons with
roscovitine, a known inhibitor for various cyclin-dependent kinases
including Cdk5 (Meijer et al., 1997), reduced the downregulation of
GluR6 ⁄ 7 and PSD95 observed with KA at 3 h (Fig. 5A and B; one-
way anova with Tukey’s post-hoc test, P < 0.01 for 3 h KA vs.
roscovitine +3 h KA). Immunolabeling of GluR6 ⁄ 7 in roscovitine-
treated neurons revealed a localization of the receptor adjacent to the
cell membrane, which was more pronounced in cells treated with KA
(Fig. 5C). Apart from roscovitine, we modulated the level or activity
of Cdk5 in hippocampal neurons using siRNA and DN constructs for
Cdk5. Data showed that the DN-Cdk5 counteracted the decrease in
PSD95 and GluR6 induced by KA in the neurons (Fig. 5D and E;
one-way anova with Bonferroni post-hoc test, P < 0.05 for KA vs.
DN-Cdk5+KA in the case of GluR6 ⁄ 7 and P < 0.01 for KA vs.
DN-Cdk5+KA in the case of PSD95). Similarly, the downregulation
of Cdk5 using siRNA prevented the decrease in GluR6 ⁄ 7 caused by
KA (Fig. 5F and G; one-way anova with Bonferroni post-hoc test,
P < 0.05 for KA vs. DN-Cdk5+KA). As the inhibition of Cdk5
affected the levels of GluR6 ⁄ 7 we hypothesized that this might affect
the calcium movements in the neurons. Thus, we used calcium
imaging as described in Materials and methods to distinguish between
DN-Cdk5-expressing or roscovitine-treated and control neurons.
However, there was no significant difference in calcium movements
between control and Cdk5-inhibited neurons (data not shown).
To study the long-term effects of Cdk5 inhibition, we analyzed the
neuronal cell death induced by KA after 24 h. Data showed that the
number of degenerating neurons was reduced in cultures treated with
DN-Cdk5 compared with KA-treated controls (Fig. 5H; one-way
anova with Bonferroni post-hoc test, P < 0.01 for control vs. KA and
P < 0.05 for KA vs. DN-Cdk5+KA). This shows that the neuronal
damage induced by KA is less in the presence of the DN-Cdk5
construct inhibiting Cdk5 activity.
Discussion
In this work, we show that treatment with an excitotoxic dose of KA
causes a rapid degeneration of mossy fiber synapses and a decrease in
GluR6 ⁄ 7 levels in rat hippocampus in vivo as well as in cultured
hippocampal neurons. The results obtained support the view that Cdk5
deregulation is instrumental in this process, as it occurs subsequent to
the cleavage of the activator protein p35 that is induced by calpain and
by the elevation of intracellular calcium levels in hippocampal neurons
after KA stimulation. In keeping with this, inhibition of Cdk5 using
roscovitine or employing DN-Cdk5 and siRNA constructs counter-
acted the decreases in GluR6 ⁄ 7 and PSD95 observed after KA in
cultured hippocampal neurons. The present results on the involvement
of Cdk5 in KA-mediated excitotoxicity add to previous findings on the
Fig. 2. KA downregulates PSD95 and GluR6 ⁄ 7 in cultured hippocampal
neurons. Hippocampal neurons were cultured from embryonic day 17 rat
hippocampus and treated with 100 lm KA and analyzed further as described in
Materials and methods. (A) Immunostaining. PSD95 immunoreactivity was
reduced in hippocampal neurons at 3 h after KA treatment. Scale bar, 5 lm. (B)
Immunoblot shows downregulation of PSD95. Values are means + SEM,
n = 3. **P < 0.01 for KA vs. control (C). (C) Immunostaining. GluR6 ⁄ 7 was
decreased within dendrites after KA stimulation. Scale bar, 20 lm. (D)
Immunoblots. Neurons were incubated with KA for various periods of time.
GluR6 ⁄ 7 decreased starting after 15 min of incubation. b-actin was used as
control (C). (E) Values are means + SEM, n = 3. **P < 0.01 for KA vs. C.
PSD, postsynaptic density.
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importance of Cdk5 in Alzheimer’s disease (Kobayashi et al., 1993;
Noble et al., 2003) and other neurological disorders (reviewed in
Dhariwala & Rajadhyaksha, 2008).
Cyclin-dependent kinase-5 has been implicated in numerous
processes in the nervous system ranging from developmental effects
in neurons to modulation of synaptic plasticity and learning in adults
(Ohshima et al., 1996; Chae et al., 1997; Zhang et al., 1997; Hawasli
& Bibb, 2007; Lai & Ip, 2009). Activation of Cdk5 requires the
binding of the activator proteins, p35 or p39, which have a rather
restricted expression in brain tissue (Tsai et al., 1994; Cai et al.,
1997). At the subcellular level, Cdk5 localizes to the cytoplasm and
nucleus (Ino & Chiba, 1996). However, the interaction of Cdk5 with
myristoylated p35 or p39 leads to the recruitment of Cdk5 to cellular
membranes both in the cell soma and within dendrites (Asada et al.,
2008). It has been shown that the cleavage of p35 into p25 affects
Cdk5 in several ways, by influencing the activity, localization and
protein–protein interactive network of Cdk5 (Kusakawa et al., 2000;
Lee et al., 2000; Patzke & Tsai, 2002). Recently, inhibition of Cdk5
activity was shown to potentiate the release of neurotransmitters and
thereby unmask so-called ‘silent’ synapses in neurons (Kim & Ryan,
2010). In the post-synaptic compartment, Cdk5 regulates dendritic
spine formation through phosphorylation of cytoskeleton-binding
proteins, including neurofilaments and microtubule-associated pro-
teins, as well as Tau and other signaling molecules (reviewed in Lai &
Ip, 2009). Activation of Cdk5 after increased neuronal activity was
shown to phosphorylate the N-terminal domain of PSD95 and
decrease the clustering of PSD95 and NMDA receptors at synapses,
whereas the inhibition of Cdk5 had the opposite effects (Morabito
et al., 2004). Cdk5 was further shown to phosphorylate the NMDA
receptor subunit 2A and to enhance NMDA-mediated currents in
hippocampal neurons (Li et al., 2001). Studies of conditionally Cdk5
gene-deleted mice showed that the degradation of NMDA receptor
subunit NMDA receptor subunit 2B and the threshold for induction of
long-term potentiation were altered in brain (Hawasli et al., 2007).
Fig. 3. KA induces a calcium- and calpain-dependent cleavage of the p35 protein in cultured hippocampal neurons. (A and B) Immunoblots. Hippocampal neurons
were treated with 100 lm KA for different times. The Cdk5 activator p35 was cleaved into the p25 fragment after KA. b-actin was used as control (C). Values are
means + SEM, n = 4. **P < 0.01 for KA treatment vs. C. (C) Fura-2 calcium imaging was performed as described in Materials and methods. Typical Ca2+ response
to KA is shown as an average trace ± SEM (a single experiment with 35 cells). For the sake of clarity, error bars are only drawn for every other point. Cells were
stimulated with increasing concentrations of KA as indicated. The vertical calibration bar indicates the ratio 340 : 380. (D) Immunoblots. Activation of calpain
produces a specific cleavage of a-spectrin shown here as the 145 kDa protein fragment. A typical experiment is shown and was repeated three times. (E and F)
Immunoblots. Hippocampal neurons were treated with the calcium chelator (1 mm BAPTA-AM) at 30 min prior to KA. BAPTA-AM reduced the cleavage of p35 to
the p25 protein. b-actin was used as control (C). Values are means + SEM, n = 4. **P < 0.01 for KA vs. C and P < 0.01 for KA+BAPTA-AM vs. KA. (G and H)
The calcium chelator EGTA and the calpain inhibitor XI decreased the KA-induced increase in p25. b-actin was used as control (C). Values are means + SEM,
n = 4. **P < 0.01 for KA vs. C. and P < 0.01 for EGTA+KA and XI+KA vs. KA.
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Recently, Cdk5 was also shown to regulate the a-amino-3-hydroxy-5-
methylisoxazole-4-propionic acid receptor subunit GluR2-mediated
synaptic activity via phosphorylation of D-catenin (Poore et al.,
2010).
In this work, we have studied the involvement of Cdk5 in
KA-induced excitotoxicity in neurons, and particularly analyzed the
synaptic proteins, GluR6 ⁄ 7 and PSD95, that are important for proper
glutamatergic neurotransmission in the mossy fibers in the hippocam-
pus. We show here that KA stimulation induced a phosphorylation of
Cdk5 and an increased cleavage of the regulatory protein p35 in
cultured hippocampal neurons. Similar changes were also observed
in hippocampus in vivo with the largest effects observed at 12 h
after KA administration. As studied in vitro, the cleavage of p35 and
the increase in p-Cdk5 depended on the increase in intracellular
Fig. 4. KA treatment induces Cdk5 phosphorylation in hippocampal neurons in culture and in vivo. Hippocampal neurons were treated with 100 lm KA for
different times and analyzed further as indicated. Administration of KA in vivo was performed as in Fig. 1. (A and B) Immunoblots. Phosphorylation of Cdk5
(p-Cdk5) was induced by KA stimulation with no changes in total Cdk5 levels. Values are means + SEM, n = 4. **P < 0.01 and *P < 0.05 for KA vs. control (C).
(C) Immunostaining of cultured neurons. Phosphorylated Cdk5 is localized particularly within neurites at 30 min after KA stimulation. Scale bar, 10 lm. (D and E)
Immunoblots. Pre-treatment with 2 mM EGTA (E2) or 2.5 mm EGTA (E2.5) or 1 mm BAPTA-AM (B) reduced the increase in p-Cdk5 induced by KA. Values are
means + SEM, n = 4. **P < 0.01 for KA vs. C and P < 0.01 for EGTA+KA and BAPTA-AM+KA treatments vs. KA. (F) In vivo experiments. KA was
administrated for 12 h. Note the increase in the levels of p25 and p-Cdk5 in the hippocampus by KA. b-actin was used as control (C). (G) Values are means + SEM,
n = 4. **P < 0.01 for 12 h KA vs. C in the case of p-Cdk5 and p25, and *P < 0.05 for 24 h KA vs. C in the case of p35.
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calcium brought about by KA as this was blocked by BAPTA-AM
and EGTA. Inhibition of the calcium-dependent protease calpain
also reduced the p35 cleavage induced by KA. This indicates that
KA can activate calpain at an early stage, which links the calcium
increase to subsequent downstream cellular events in excitotoxicity.
Our study with KA confirms previous data showing a cleavage of
p35 after activation of GluRs using NMDA, a-amino-3-hydroxy-5-
methylisoxazole-4-propionic acid and glutamic acid as agonists
(Kerokoski et al., 2004). However, the links between p35 and the
deregulation of Cdk5 and alterations in synaptic proteins and
neuronal excitotoxicity induced by KA have not been documented
before.
It has been shown that KARs participate in the excitatory post-
synaptic currents occurring between the mossy fibers and CA3
Fig. 5. Inhibition of Cdk5 counteracts KA-induced downregulation of PSD95 and GluR6 in cultured hippocampal neurons. Hippocampal neurons were treated with
100 lm KA alone or in the presence of the cyclin-dependent kinase inhibitor roscovitine (RV). In some experiments, neurons were transfected with siRNA against
Cdk5 or with the dominant-negative (DN) Cdk5 construct prior to KA treatments. (A and B) Immunoblots. Addition of RV counteracts the downregulation of
GluR6 ⁄ 7 and PSD95 induced by KA. Values are means ± SEM, n = 3. **P < 0.01 for RV+KA vs. KA at 3 h. (C) Confocal images of hippocampal neurons were
acquired as described in Materials and methods. Note the increased GluR6 ⁄ 7 immunostaining by roscovitine in KA-treated neurons. Scale bar, 50 lm. (D and E)
Immunoblots. Expression of DN-Cdk5-hemagglutinin reduced the decrease in GluR6 ⁄ 7 and PSD95 induced by KA at 3 h. Values are means ± SEM, n = 3.
*P < 0.05 or **P < 0.01 for DN-Cdk5+KA vs. KA in the case of both GluR6 ⁄ 7 and PSD95. (F and G) Immunoblots. Cdk5-siRNA reduced Cdk5 levels in neurons
at 5 days of transfection and reduced the decrease in GluR6 ⁄ 7 induced by KA. Values are means ± SEM, n = 3. *P < 0.05 for siRNA+KA vs. KA. (H) Neurons
transfected with DN-Cdk5-EGFP or with EGFP as controls (C) were stimulated with 100 lm KA for 24 h. Nuclei were labeled with Hoechst blue and the number of
transfected cells with condensed or fragmented chromatin was counted as an index of degenerating cells. Values are means ± SEM, n = 3. **P < 0.01 for KA vs.
C and P < 0.05 for DN-Cdk5+KA vs. KA.
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pyramidal cells (Castillo et al., 1997). In the pre-synaptic compart-
ment, KARs affect the neurotransmitter release through activation of
GluR6 ⁄GluR7 (Lerma, 2006). In addition, extrasynaptic KARs, in
CA1 pyramidal cells, may increase neuronal excitability through a
metabotropic action (Melyan et al., 2002). In GluR6 gene-deleted
mice, the mossy fiber excitatory post-synaptic currents and the pre-
synaptic actions of KARs are missing (Mulle et al., 1998; Contrac-
tor et al., 2001). Recently, KARs were shown to control the efficacy
of spike transmission between pre-synaptic granule cells and CA3
pyramidal cells by a combination of pre- and post-synaptic actions
(Sachidhanandam et al., 2009). Polymorphisms in the GluR6 gene
have been associated with a number of mental disorders, e.g.
schizophrenia and bipolar disorders (Beneyto et al., 2007; Black-
wood et al., 2007). As shown in GluR6 gene-deleted mice,
activation of GluR6 is central for epileptiform seizures induced by
KA and for cell death in the hippocampal CA3 area (Mulle et al.,
1998).
In this work, we have identified Cdk5 as an important downstream
target for the action of KA in hippocampal neurons. Blocking of the
Cdk5 pathway by roscovitine or using the DN-Cdk5 construct restored
the levels of GluR6 ⁄ 7 and PSD95 in hippocampal neurons stimulated
by KA. Roscovitine is an inhibitor of the cyclin-dependent kinase
family of proteins including Cdk5, and it has been shown to be
neuroprotective in animal models for focal ischemia and in different
tauopathies (Wen et al., 2007; Menn et al., 2010). The structurally
related compound olomoucine also reduces ischemia-induced reactive
astrogliosis (Zhu et al., 2007). However, both roscovitine and olomou-
cine may also have unwanted effects that may preclude their direct
application in neurological disorders. It was recently reported that the
Cdk5 ⁄ p25 inhibitory peptide, which targets only the deregulated
Cdk5 ⁄ p25 complex (Zheng et al., 2002), showed promising effects in
nerve cell cultures (Kanungo et al., 2009). However, more studies on
this peptide are needed to elucidate its effects in vivo as a potentially
beneficial agent in neurodegeneration (Kanungo et al., 2009).
Taken together, the present findings show an essential function of
Cdk5 in the regulation of synaptic integrity and GluR6 ⁄ 7 and PSD5
levels in excitotoxicity induced by KA in hippocampal neurons. Cdk5
has different protein target proteins and affects various signaling
events in neurons. The mechanisms through which Cdk5 influences
synaptic proteins and excitotoxicity in neurons remain to be studied
further.
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